Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/20155
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSmith, SG-
dc.contributor.authorZelmer, A-
dc.contributor.authorBlitz, R-
dc.contributor.authorFletcher, HA-
dc.contributor.authorDockrell, HM-
dc.date.accessioned2020-02-03T12:39:42Z-
dc.date.available2016-10-
dc.date.available2020-02-03T12:39:42Z-
dc.date.issued2016-09-09-
dc.identifier.citationSmith SG, Zelmer A, Blitz R, Fletcher HA, Dockrell HM. Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants. Vaccine. 2016 Oct 17;34(44):5298-305.en_US
dc.identifier.issn0264-410X-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/20155-
dc.description.abstractBackground: Vaccination with Bacillus Calmette Guerin (BCG) protects infants against childhood tuberculosis however the immune mechanisms involved are not well understood. Further elucidation of the infant immune response to BCG will aid with the identification of immune correlates of protection against tuberculosis and with the design of new improved vaccines. The purpose of this study was to investigate BCG-induced CD4+ T-cell responses in blood samples from infants for cytokine secretion profiles thought to be important for protection against tuberculosis and compare these to PBMC-mediated in vitro mycobacterial growth inhibition. Methods: Blood from BCG-vaccinated or unvaccinated infants was stimulated overnight with Mycobacterium tuberculosis (M. tb) purified protein derivative (PPD) or controls and intracellular cytokine staining and flow cytometry used to measure CD4+ T-cell responses. PBMC cryopreserved at the time of sample collection were thawed and incubated with live BCG for four days following which inhibition of BCG growth was determined. Results: PPD-specific IFNc+TNFa+IL-2+CD4+ T-cells represented the dominant T-cell response at 4 months and 1 year after infant BCG. These responses were undetectable in age-matched unvaccinated infants. IL-17+ CD4+ T-cells were significantly more frequent in vaccinated infants at 4 months but not at 1-year post-BCG. PBMC-mediated inhibition of mycobacterial growth was significantly enhanced at 4 months post-BCG as compared to unvaccinated controls. In an analysis of all samples with both datasets available, mycobacterial growth inhibition correlated significantly with the frequency of polyfunctional (IFNc+TNFa+IL-2+) CD4+ T-cells. Conclusions: These data suggest that BCG vaccination of infants induces specific polyfunctional T-helper-1 and T-helper-17 responses and the ability, in the PBMC compartment, to inhibit the growth of mycobacteria in vitro. We also demonstrate that polyfunctional T-helper-1 cells may play a role in growth inhibition as evidenced by a significant correlation between the two.en_US
dc.description.sponsorshipThis work was supported by the European Commission within the 7th framework program (FP7) NEWTBVAC (Grant No. HEALTH-F3-2009-241745), by the European Tuberculosis Vaccine Initiative (Grant No. TBVI-12 NORAD) and by the European Commission within Horizon2020 TBVAC2020 (Grant No. H2020 PHC- 643381).en_US
dc.format.extent5298 - 5305-
dc.languageen-
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectBCGen_US
dc.subjectT-cellsen_US
dc.subjectCytokinesen_US
dc.subjectInfantsen_US
dc.subjectPolyfunctionalen_US
dc.titlePolyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infantsen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1016/j.vaccine.2016.09.002-
dc.relation.isPartOfVaccine-
pubs.issue44-
pubs.publication-statusPublished-
pubs.volume34-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdf933.59 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.